FDA-Cleared Therapy for Pediatric Sleep Apnea From Vivos Offers Parents and Providers New Hope [Yahoo! Finance]
Vivos Therapeutics, Inc. (VVOS)
Company Research
Source: Yahoo! Finance
Vivos Therapeutics, with its groundbreaking FDA-cleared treatments, is leading the charge in tackling this silent epidemic with innovative, non-surgical solutions that promise transformative health outcomes for children and their families. LITTLETON, Colo. Dec. 16, 2024 /PRNewswire-PRWeb/ -- Pediatric Obstructive Sleep Apnea (OSA) is a silent health crisis affecting an estimated 10 million children in the United States , with studies showing that those who snore have a 20% chance of developing the condition. (1) Left untreated, it can impair cognitive development and increase long-term risks such as attention deficit disorders. Despite its prevalence, awareness remains critically low. "After decades of research, many parents—and even pediatricians—still underestimate the chronic and harmful nature of OSA, often dismissing symptoms without proper evaluation," states Kirk Huntsman , CEO of Vivos Therapeutics The Complex Link Between Pediatric OSA and ADHD: An Overlapping Challenge
Show less
Read more
Impact Snapshot
Event Time:
VVOS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VVOS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VVOS alerts
High impacting Vivos Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VVOS
News
- Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules [Yahoo! Finance]Yahoo! Finance
- Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesGlobeNewswire
- All You Need to Know About Vivos Therapeutics (VVOS) Rating Upgrade to Buy [Yahoo! Finance]Yahoo! Finance
- FDA-Cleared Therapy for Pediatric Sleep Apnea From Vivos Offers Parents and Providers New HopePR Web
- Groundbreaking Collaboration: Vivos Therapeutics and Cellev8 Nutrition Join Forces to Address Sleep Apnea and Oxidative Stress [Yahoo! Finance]Yahoo! Finance
VVOS
Earnings
- 11/14/24 - Beat
VVOS
Sec Filings
- 12/23/24 - Form 8-K
- 12/20/24 - Form SCHEDULE
- 11/27/24 - Form 8-K
- VVOS's page on the SEC website